Such a fun experience!! #HOPLive24

Thank you to Conquer Cancer, the ASCO Foundation Herbert Irving Comprehensive Cancer Center and all of my mentors and colleagues for the support! Very grateful to receive this #ASCO merit award and looking forward to presenting our work at #ASCO 2024 Michael May Melissa Accordino, MD, MS

Congratulations to the 2024 ASCO Annual Meeting Merit Award and Special Merit Award recipients. These awards will support 140 students and trainees who are first authors on abstracts selected for presentation at #ASCO24 . View the full list of recipients: brnw.ch/21wIXps

Come join us at room 28 to discuss oligometastatic disease! Ralph Weichselbaum AACR Herbert Irving Comprehensive Cancer Center The University of Chicago

Eternally grateful for the mentorship at Herbert Irving Comprehensive Cancer Center and this wonderful group of colleagues!

Rare diseases add to our knowledge. 🧠 #RareDiseaseDay #RDDNIH

Today is #RareDiseaseDay ! Rare diseases are not a rare occurrence—they affect an estimated 30 million people in the U.S.

Tune in for Rare Disease Day at the NIH to learn more: spr.ly/6013XKhwW #RDDNIH

🔥 Our viewpoint article on CheckMate 901 is now out in Med by Cell Press. We discuss its findings, how they relate to EV-302, & the importance of personalized treatment. Grateful to mentorship by Neeraj Agarwal, MD, FASCO and Petros Grivas! Link to full article 👉 bit.ly/3HVoOVk

A P2 single-arm study testing SBRT, adenosine signaling modulation, and immune checkpoint inhibition for men with hormone-sensitive oligometastatic #ProstateCancer (SBRT-AMICO) - Kristine Lacuna, MD Herbert Irving Comprehensive Cancer Center. #GU24 written coverage with Rashid K. Sayyid > bit.ly/3Sg9Mhv

FDA issued a guidance for industry, “Rare Diseases: Considerations for the Development of Drugs and Biological Products.”

View guidance: fda.gov/regulatory-inf…

Abstract titles are now available for #GU24 !

Preview the science and plan your schedule here: brnw.ch/21wFhy0

Co-sponsors: ASTRO, Society of Urologic Oncology

Excited to present our joint efforts in R/R PTCL between Columbia & Cornell at ASH! Incredibly grateful for my amazing mentorship with Jennifer Amengual Barbara Pro and Dr Ruan + collaboration with Caitie Gribbin! More great things to come! 🎉Herbert Irving Comprehensive Cancer Center Weill Cornell Medicine NewYork-Presbyterian

Grateful for the opportunity to present our work on G1q in MM

Poster 3369
#ASH23

Raj Chakraborty Manni Mohyuddin Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Riyasha Dahal

FDA approved nirogacestat (OGSIVEO, SpringWorks Therapeutics) for adult patients with progressing desmoid tumors who require systemic treatment. This is the first approved treatment for desmoid tumors.
fda.gov/drugs/resource…
#OCENewsBurst

Applications for the February 2024 FDA Oncology-ASCO Fellows Day Workshop are now being accepted until Nov 27! Apply online here asco.smapply.org/prog/FebruaryF…, and look forward to meeting the next group of fellows in a few months! #OCEProjectSocrates

5 years from pitching trial Regeneron to publication Cancer Cell. Science is hard, but living with cancer is so much harder!

Thank you to patients and families 🫶🏼 for participating in and contributing to science. We hope it has tsunami 🌊 (not ripples) of impact. /11

Pleased to see that our Hem-Onc Fellows Network article on Fellowship application has been 'FEATURED' at ASCO Connection and is also among the 'MOST READ' articles!

Grateful to Fionnuala Crowley Franco Castillo Tokumori Kristine Lacuna, MD Alma Habib, MD and everyone who took time to go through the article

Fred Hutch #myeloma experts Drs. Andrew Cowan, Kara Cicero and Rahul Banerjee, MD, FACP, are leading speakers for an upcoming patient education event called the @HealthtreeMM Roundtable in Seattle on October 14, 2023!
Learn more and register: bit.ly/3PtMRiJ #MML #MMsm

The 2023 #NYCProstateSummit kicks off on Sunday, September 10th at 10:30 am. Join experts from Weill Cornell Medicine NewYork-Presbyterian Memorial Sloan Kettering Cancer Center and Columbia Medicine to hear the latest updates in #ProstateCancer care. Event is free, register today: prostatesummit.org

Dr. Ingham's research work focuses on the rare #leiomyosarcoma . They account for less than 1% of cancer diagnoses each year. His research shows with two treatments paired together, cancer growth slowed for this rare disease. Read the Researcher Spotlight: brnw.ch/21wC3oK